Turning Point Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (Nasdaq: TPTX), a precision oncology company developing next-generation […]